A new study has discovered that ophthalmic acid, a molecule in the brain, acts like a neurotransmitter to regulate motor ...

Previous studies in a rat model of Parkinson disease (PD) have shown that dyskinesia induced by L-DOPA—a treatment-limiting adverse effect of long-term administration—is caused by the release ...

We examined the effect of L-DOPA in the dose used for GH stimulation on the LH,FSH and Pr levels in 9 subjects with Turner syndrome, who had never received estrogens. We found the following (mean ...

The odds ratio for exposure to L-dopa in the IPD patients with PN was 12.4 (95% confidence interval, 1.4–109.1). There were no differences between the groups in the use of other PD drugs ...

A research team is the first to reveal that a molecule in the brain – ophthalmic acid – unexpectedly acts like a ...

A research team from the University of California, Irvine is the first to reveal that a molecule in the brain – ophthalmic ...

They identified ophthalmic acid as an alternative neurotransmitter through detailed behavioral, biochemical, and ...

A research team has revealed that a molecule in the brain -- ophthalmic acid -- unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic ...

卡罗林斯卡研究所的研究人员已经确定了一种机制，该机制负责帕金森病多巴胺替代疗法引起的严重精神并发症。这些发现的结果最近发表在《Molecular Psychiatry》上。 卡罗林斯卡研究所的研究人员已经确定了一种机制，该机制负责帕金森病多巴胺替代疗法引起的 ...

Continuous intracerebroventricular administration of a novel dopamine formulation appears safe in Parkinson's disease and may ...

M. pruriens (velvet bean or cowage) can be found in food or supplement form. It contains levodopa (L-dopa), a potent bioactive ingredient that increases levels of dopamine, a neurotransmitter ...

The voluminous papers of the celebrated neurologist include letters, notebooks, drafts and other traces of a man who couldn’t ...